Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BSX
MRNA
Add up to 3 more stocks
BSX
Boston Scientific Corporation
+3.05%
$52.01+1.54Delayed quote: Aug 19, 2026, 4:00 PM EDT
Market Cap
$77.31B
52W Range
$42.20 - $109.50
MRNA
Moderna, Inc.
+176.97%
$174.38+111.42At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$69.19B
52W Range
$22.28 - $176.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 21.14 | N/A |
| Forward P/E | 15.74 | N/A |
| P/B Ratio | 3.10 | 10.21 |
| P/S Ratio | 3.68 | 30.99 |
| P/FCF Ratio | 21.30 | N/A |
| EV/EBITDA | 15.41 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.2% | 55.4% |
| Operating Margin | 21.5% | -158.1% |
| Net Margin | 17.5% | -141.4% |
| ROE | 14.7% | -46.6% |
| ROA | 8.1% | -28.8% |
| ROIC | 10.6% | -39.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.24 | 2.29 |
| Quick Ratio | 0.74 | 2.18 |
| Debt/Equity | 0.51 | 0.19 |
| Interest Coverage | 11.38 | -307.40 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.